[ BPE LAB OVERVIEW ]
Advancing Global Health through Pharmacy and Big Data Analytics
The Big-data Analytics Pharmacoepidemiology (BPE) Lab at Ewha Womans University leverages large-scale healthcare databases including NHIS, HIRA, UK Biobank, and All of US to generate robust real-world evidence. Our research bridges the gap between traditional epidemiology and molecular science by integrating biomarkers and multi-omics data for enhanced drug safety and effectiveness.
[ VISION ]
Integrating healthcare big data with cutting-edge omics technologies
to advance evidence-based pharmaceutical policy and precision medicine
[ MISSION ]
• Generating real-world evidence on drug safety and effectiveness
• Developing innovative research linking biomarkers with pharmacoepidemiology
• Training the next generation in advanced healthcare big data analytics
Key Research
Pharmacoepidemiology
Analyzing large healthcare data to evaluate real-world effects and improve causal inference.
Pharmacovigilance
Detecting drug adverse event signals precisely using global databases to ensure patient safety.
Aging
Analyzing links between biological aging and drug epidemiology to promote health in elderly eras.
Multi-omics
Integrating data to identify new biomarkers and predict personalized drug responses accurately.
News & Notice
2026.04.03
We are seeking motivated graduate students for the MS and MS-PhD integrated programs beginning Fall 2026.
2026.04.03
Ewha Selected for MFDS Global Regulatory Science Leader Development Program (2026–2030)
2026.03.13
Prof. Dongwon Yoon has been awarded a three-year research grant from the National Research Foundation of Korea (NRF) under the Early Career Researcher Program.